EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AI‐Guided SERS Defines a Pan‐Cancer Diagnostic Biomarker

Cai Zhang, Wen-Hui Zhao, Duo Zuo, Tianxing Zhou, Wenjing Hou, Lingwei Wang, Shangheng Shi, Yang Yang, Yuanyuan Liu, Shao-Kai Sun, Li Ren, Zhaoxiang Ye und 4 weitere

Advanced Science · 2026-02 · 13 (7)

DOI: 10.1002/advs.202516268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.11.2025. Verfasst von Cai Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Tianjin's Clinical Re…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Spectrum Analysis, Raman, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Public Health Science and Technology Major Project, Tianjin Health Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early and accurate detection of multiple cancers through a single test remains an unmet clinical need, hindered by current limitations in accuracy, throughput, automation, and multiplexing. Here, we present an AI‐powered SERS chip that combines automated exosome capture with AI‐enabled molecular fingerprinting to accurately distinguish ten common cancer types from a single serum test. The system employs a peptide‐functionalized SERS chip enabling the selective enrichment of exosomes directly from patient serum, enhancing label‐free Raman fingerprint signals. AI‐driven spectral analysis achieved 97.4% accuracy in distinguishing cancer from healthy samples, 97.08% accuracy for early‐stage cancer detection, and 93.89% accuracy in classifying ten common cancer types, including breast, thyroid, esophageal, kidney, pancreatic, duodenal, lung, colorectal, ovarian, and gastric cancers. Crucially, based on molecular profiling, we identified exosomal deoxyadenosine triphosphate as a promising pan‐cancer biomarker consistently upregulated across diverse tumor types. This discovery establishes a potential pan‐cancer diagnostic marker, while the fully automated, scalable platform offers significant promise for clinical translation in early and differential cancer diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorSpectrum Analysis, RamanNeoplasmsHumansExosomes

Stichwörter der Autor:innen

artificial intelligenceexosomesliquid biopsymolecular fingerprintingpan‐cancer biomarker

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer,…
  • Department of Radiology, Tianjin Medical University General Hospital, Heping District, Tianjin, 300052, China.
  • Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, Hexi District, Tianjin, 300060, China.
  • Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Cente…
  • Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Hexi District, Tianjin, 300060, China.
  • School of Medical Imaging, Division of Medical Technology, Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University, Hexi District, Tianjin, 300023, China.

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National Natural Science Foundation of China
  • Tianjin Public Health Science and Technology Major Project
  • Tianjin Health Research Project
  • Tianjin Education Commission Research Project
  • National University of Singapore
  • National Medical Research Council
  • National Research Foundation
  • Agency for Science, Technology and Research (A*STAR)

Zitieren

APA

Zhang, C., Zhao, W. H., Zuo, D., Zhou, T., Hou, W., Wang, L., Shi, S., Yang, Y., Liu, Y., Sun, S. K., Ren, L., Ye, Z., Liu, D., Li, D., Chen, X., & Hao, J. (2026). AI‐Guided SERS Defines a Pan‐Cancer Diagnostic Biomarker. Advanced Science, 13(7). https://doi.org/10.1002/advs.202516268

Vancouver

Zhang C, Zhao WH, Zuo D, Zhou T, Hou W, Wang L, et al. AI‐Guided SERS Defines a Pan‐Cancer Diagnostic Biomarker. Advanced Science. 2026;13(7). doi:10.1002/advs.202516268

BibTeX
@article{Zhang2026,
  author = {Zhang, Cai and Zhao, Wen-Hui and Zuo, Duo and Zhou, Tianxing and Hou, Wenjing and Wang, Lingwei and Shi, Shangheng and Yang, Yang and Liu, Yuanyuan and Sun, Shao-Kai and Ren, Li and Ye, Zhaoxiang and Liu, Dingbin and Li, Dong and Chen, Xiaoyuan and Hao, Jihui},
  title = {AI‐Guided SERS Defines a Pan‐Cancer Diagnostic Biomarker},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {7},
  doi = {10.1002/advs.202516268}
}
Kostenlos starten →